RxDoctor Payments Data

Catherine Wagner

Family · Ironton, OHNPI 1760902001

Payments from drug & device makers

$3,113in general payments, 2019–2025

Across 206 payments — averaging $15.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$879
  • AbbVie$692
  • Pfizer$380
  • Lilly USA, LLC$361
  • Novo Nordisk$253
  • Gilead$201
  • plus $346 from 13 others

What the payments were for

  • Food & beverage$3,101100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,113 in reported general payments places this provider in the 85th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$1,049
Medicare patients
39
Services billed
94

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide76$80,341
TrulicityDulaglutide42$50,373
FarxigaDapagliflozin Propanediol39$34,957
MounjaroTirzepatide24$24,592
EliquisApixaban17$24,489
JardianceEmpagliflozin14$21,846
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$13,983
Tresiba Flextouch U-100Insulin Degludec22$10,650
LinzessLinaclotide11$9,409
Lantus SolostarInsulin Glargine,hum.Rec.Anlog15$2,169
Pregabalin59$1,653
Albuterol Sulfate HfaAlbuterol Sulfate48$1,418
Janumet XrSitagliptin Phos/Metformin Hcl22$1,344
Celecoxib23$1,195
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl14$1,123

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$253$80,34176 claims
Lilly USA, LLCTrulicity, Mounjaro$361$74,96566 claims
AstraZenecaFarxiga, Breztri Aerosphere$879$48,94055 claims
PfizerEliquis$380$24,48917 claims
Boehringer IngelheimJardiance$18$21,84614 claims
AbbVieLinzess$692$9,40911 claims
MerckJanumet Xr$17$1,34422 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,812 family providers in Ohio.

Other family in Ironton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →